.<]Q#KW,MDV'^?)AL>QKF1M$[(=_19^&G6P<+0A%,%36AYB
SYSTEM PROCESSING...
.<]Q#KW,MDV'^?)AL>QKF1M$[(=_19^&G6P<+0A%,%36AYB
SYSTEM PROCESSING...
Posted: 2025-04-22 09:14:58 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-22 09:15:15 UTC
Verified By
Rollup News
A tumor-derived metabolite, phosphoethanolamine, accumulates in the tumor microenvironment and suppresses T cell function, presenting a novel target for improving cancer immunotherapy.
Tumor-derived phosphoethanolamine suppresses T cell function.
Accumulation of phosphoethanolamine in the tumor microenvironment.
New target identified for enhancing cancer immunotherapy.
Tumor-derived metabolites suppressing immune cell function.
Overcoming the inhibitory effects of phosphoethanolamine on T cells.